MET and prostate carcinoma: In addition, in vitro and in vivo studies demonstrated that the LNCaP-Met cell lines exhibited the greatest proliferative, migratory and tumorigenic potential, indicating a potential association between c-Met-mediated signaling pathways, EMT and prostate cancer aggressiveness.